2011
DOI: 10.1016/j.reuma.2010.06.004
|View full text |Cite
|
Sign up to set email alerts
|

Calidad de vida relacionada con la salud tras terapia anti-factor de necrosis tumoral alfa en pacientes con artritis reumatoide. Un estudio piloto

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 14 publications
1
1
0
Order By: Relevance
“…Such an observation highlights the need for long-term studies, in order to assess whether improvement gained is sustained and to what extent. Findings from this study are in accordance with results obtained from the generic SF-36 questionnaire in a study conducted on a Spanish population [20]. Findings from both HRQOL questionnaires used indicate the clinical effectiveness of TNF- α antagonists in achieving a better QOL, as documented in various studies [20, 21].…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…Such an observation highlights the need for long-term studies, in order to assess whether improvement gained is sustained and to what extent. Findings from this study are in accordance with results obtained from the generic SF-36 questionnaire in a study conducted on a Spanish population [20]. Findings from both HRQOL questionnaires used indicate the clinical effectiveness of TNF- α antagonists in achieving a better QOL, as documented in various studies [20, 21].…”
Section: Discussionsupporting
confidence: 90%
“…ACR/EULAR remission (<2.6) was met by 15.4% ( n = 2) of subjects. Abalos Medina [20] reported a higher prevalence of ACR/EULAR remission, yet this must be interpreted in the light of the limited number of participants and length of the current study.…”
Section: Discussionmentioning
confidence: 82%